CD8A and neoplasm: All things considered, our findings show that adoptive activated CD8+ T cells, in response to the DC/tumor fusion vaccine and LPS-RGD-Nb36-DOX, limit the growth of implanted tumors in mice by preventing tumor cell division and increasing tumor cell death.